ChREBP was also associated with up-regulation of several cytokines (TNF-α, IL-1β, and IL-6) in patients with type 2 diabetes mellitus, promoting the inflammatory responses and apoptosis of mesangial cells (32). This evidence concerns the gene IL6 and diabetes mellitus.